FDA Grants Priority Review For Pfizer's Talzenna sNDA For Men With Homologous Recombination Repair Gene-Altered Metastatic Castration-Sensitive Prostate Cancer

뉴스 본문을 불러오고 있어요.

FDA Grants Priority Review For Pfizer's Talzenna sNDA For Men With Homologous Recombination Repair Gene-Altered Metastatic Castration-Sensitive Prostate Cancer | 웨이프 WAPE

FDA Grants Priority Review For Pfizer's Talzenna sNDA For Men With Homologous Recombination Repair Gene-Altered Metastatic Castration-Sensitive Prostate Cancer

기사 요약

관련 종목

댓글 —